Maria Sainz is recorded as CEO and Board Member at Hyperfine, Inc. (HYPR) and Board Member at Pulse Biosciences, Inc. (PLSE) since January 1, 2025. The newest filing on record that lists Maria Sainz as CEO and Board Member at Hyperfine, Inc. (HYPR) is dated April 8, 2026. The newest filing on record that lists Maria Sainz as Board Member at Pulse Biosciences, Inc. (PLSE) is dated May 11, 2026. Maria Sainz was last confirmed as Board Member at Orthofix Medical Inc. (OFIX) in a filing dated April 29, 2021. Pulse Biosciences, Inc. reported in an 8-K filed January 9, 2026 that Maria Sainz was appointed Board of Directors, effective January 8, 2026. Hyperfine, Inc. reported in an 8-K filed October 6, 2022 that Maria Sainz was appointed President and Chief Executive Officer, effective October 24, 2022. The proxy statement of Hyperfine, Inc. reports total compensation of $896,817 for Maria Sainz in fiscal 2025, including a base salary of $582,231. Disclosed compensation is on record for 4 fiscal years. Maria Sainz has spoken on 16 earnings calls and 1 other investor event across 1 company, most recently for Hyperfine, Inc. on August 6, 2026. Hyperfine, Inc. is classified in the Medical Devices industry within the Healthcare sector. Pulse Biosciences, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Hyperfine, Inc. includes Art Cohen (CEO and Board Member), Dave Scott (CEO), R. Scott Huennekens (CEO) and 7 others.
“On January 8, 2026, the Board of Directors (the “Board”) of Pulse Biosciences, Inc. (the “Company”) elected Maria Sainz to the Board, effective immediately.”
Pulse Biosciences, Inc. Form 8-K, filed January 9, 2026
· Read the filing
“On October 6, 2022, Hyperfine, Inc. (the "Company") announced that Maria Sainz, one of the Company's current directors, was appointed by the Board of Directors of the Company (the "Board") as President and Chief Executive Officer of the Company, effective as of October 24, 2022 (the "Appointment Date").”
Hyperfine, Inc. Form 8-K, filed October 6, 2022
· Read the filing
Maria Sainz on recent calls
“On the call with me today is our Chief Administrative Officer and Chief Financial Officer, Brett Hale. The second quarter was another strong quarter for Hyperfine as we continue to execute across our commercial, operational, and financial priorities.”
“On the call with me today is our Chief Administrative Officer and Chief Financial Officer, Brad Hale. The first quarter was a strong start to 2026 as we executed across our commercial and financial priorities.”
“On the call with me today is our Chief Administrative Officer and Chief Financial Officer, Brett Hale. Fourth quarter revenue of over $5 million demonstrated our very strong performance with the next generation subsystem for the second straight quarter.”
“On the call with me today is our Chief Administrative Officer and Chief Financial Officer, Brett Hale. The third quarter marked an important new beginning for our business, driven by the launches of our next-generation subsystem and the Optive AI software.”
